Hengrui Medicine (01276.HK) spent 6.794 million yuan to repurchase 125,000 A-shares on August 12.

Zhitong Finance App news, Hangzhou Huirui Pharmaceutical (01276.HK) announced that the company will spend 6.794 million yuan on August 12, 2026, to repurchase 125,000 A shares, with a repurchase price ranging from 54.15 to 54.41 yuan per share.